BE903610A - DEVICES CONTAINING SUSTAINED RELEASE ANABOLIZING IMPLANTS - Google Patents

DEVICES CONTAINING SUSTAINED RELEASE ANABOLIZING IMPLANTS

Info

Publication number
BE903610A
BE903610A BE1/011375A BE1011375A BE903610A BE 903610 A BE903610 A BE 903610A BE 1/011375 A BE1/011375 A BE 1/011375A BE 1011375 A BE1011375 A BE 1011375A BE 903610 A BE903610 A BE 903610A
Authority
BE
Belgium
Prior art keywords
implants
sustained release
devices containing
anabolizing
containing sustained
Prior art date
Application number
BE1/011375A
Other languages
French (fr)
Original Assignee
Ct De Rech S Biolog Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Rech S Biolog Virbac filed Critical Ct De Rech S Biolog Virbac
Publication of BE903610A publication Critical patent/BE903610A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Des dispositifs contenant des implants anabolisants à libération prolongée, sont constitués, d'une matrice solide, à base de polymères insolubles hydrophobes associés à des esters de glycérol, de substances dites de charge et d'une ou plusieurs substances actives. Application : Utilisation comme facteur de croissance hormonal chez les bovidés.Devices containing anabolic implants with sustained release, consist of a solid matrix, based on insoluble hydrophobic polymers associated with glycerol esters, so-called filler substances and one or more active substances. Application: Use as a hormonal growth factor in cattle.

BE1/011375A 1984-11-22 1985-11-08 DEVICES CONTAINING SUSTAINED RELEASE ANABOLIZING IMPLANTS BE903610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (en) 1984-11-22 1984-11-22 EXTENDED RELEASE ANABOLIZING IMPLANTS

Publications (1)

Publication Number Publication Date
BE903610A true BE903610A (en) 1986-05-09

Family

ID=9310081

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011375A BE903610A (en) 1984-11-22 1985-11-08 DEVICES CONTAINING SUSTAINED RELEASE ANABOLIZING IMPLANTS

Country Status (9)

Country Link
AU (1) AU585280B2 (en)
BE (1) BE903610A (en)
DE (1) DE3539408A1 (en)
FR (1) FR2573307B1 (en)
GB (1) GB2167662B (en)
IT (1) IT1188195B (en)
NL (1) NL8503227A (en)
NZ (1) NZ214179A (en)
ZA (1) ZA858486B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573783B2 (en) * 1984-01-31 1988-06-23 International Foundation For Biochemical Endocrinology Method for promoting growth and improved meat quality with female steroidal hormones
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2753904B1 (en) * 1996-10-01 1998-10-30 Gattefosse Ets Sa PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE OF ACTIVE SUBSTANCE, INCLUDING A MATRIX, AND MANUFACTURING PROCESS
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
WO2000004897A1 (en) * 1998-07-20 2000-02-03 Peptech Limited Bioimplant formulation
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
WO2000025743A2 (en) * 1998-11-04 2000-05-11 Schering Corporation Improved growth stimulant compositions
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
PE20010404A1 (en) 1999-06-11 2001-04-09 Watson Pharmaceuticals Inc COMBINATION OF NON-ORAL ANDROGENIC STEROIDS AND ESTROGENIC COMPOUNDS AND THEIR USE IN WOMEN
CA2391950A1 (en) * 1999-12-16 2001-06-21 Todd P. Foster Implant composition containing melengestrol acetate and trenbolone acetate
BR0207052A (en) 2002-10-15 2004-08-10 Natura Cosmeticos Sa Solid Cosmetic Makeup
US20100144687A1 (en) 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215137A (en) * 1923-02-23 1924-05-08 Frank Leslie Gridner Improvements in and relating to adjustable chairs
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
FR2239988A1 (en) * 1973-08-08 1975-03-07 Aries Robert Animal hormone implants - comprising a mixt. of hormone and fatty acid ester of hormone
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
FI63335B (en) * 1979-02-02 1983-02-28 Orion Yhtymae Oy FARING REFERENCE FOR A TABLETTER WITH A LIGHT LIGHT OF AN EFFECTIVE
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method

Also Published As

Publication number Publication date
ZA858486B (en) 1986-06-25
GB2167662B (en) 1988-11-30
FR2573307B1 (en) 1988-06-10
GB8527915D0 (en) 1985-12-18
NL8503227A (en) 1986-06-16
AU4998285A (en) 1986-05-29
IT8522829A0 (en) 1985-11-14
AU585280B2 (en) 1989-06-15
IT1188195B (en) 1988-01-07
FR2573307A1 (en) 1986-05-23
NZ214179A (en) 1989-06-28
GB2167662A (en) 1986-06-04
DE3539408A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
BE903610A (en) DEVICES CONTAINING SUSTAINED RELEASE ANABOLIZING IMPLANTS
UA29563C2 (en) Microcapsule for prolonged release of physiologically active peptide
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
AU3065989A (en) Polypeptide compounds having growth hormone releasing activity
MY101593A (en) Sustained release preparation.
DE59905954D1 (en) DIALKYL FUMARATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
BR9610790A (en) Gel formulations containing growth factors
BR9407560A (en) Thermoplastic elastomer copolymers grafted with silicone and hair and skin treatment compositions containing these copolymers
DE69634670D1 (en) ACTIVE ANODE MATERIAL AND NON-WATER SECONDARY BATTERY
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
IL87886A (en) Pharmaceutical composition having antiprogestational and anti-estrogenic activities for gynecological use
IT1307829B1 (en) DENTAL PROSTHESIS WITH MEANS FOR THE RELEASE OF DRUGS OR SPECIFIC FACTORS TO PREVENT THE ONset OF INFECTIONS AND / OR PROMOTE
TR199901250T2 (en) Therapeutic agents.
IL125088A0 (en) Modulation of TH1/TH2 cytokine expression
RU96116802A (en) DRESSING
TR199701520T1 (en) Cell lineage that produces analgesic compounds for pain relief.
DK0613368T3 (en) Skin regenerating cosmetic composition
TR200000249T2 (en) Transdermal therapeutic system (TTS) for the passage of an active substance into an organism and its application to the skin
EP0507772A4 (en) Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof.
FR2569987B1 (en) AUTONOMOUS IMPLANTABLE DEVICE AND ITS USE FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES IN THE HUMAN BODY
BR9912566A (en) Microparticles prepared from cycloolefins copolymers and their application for the controlled release of active substances
ATE206911T1 (en) SOLID MEDICINAL FORM WITH ACTIVE INGREDIENTS DISTRIBUTED IN POLYMERIC MATERIAL
MY106238A (en) Solid silicone-based agricultural compositions with biological action
MA21471A1 (en) TURNING COMPOSITION AND ITS USE IN TURNING AND POST-TURNING OF ANIMAL SKIN.
AR017170A1 (en) OPHTHALMOLOGICAL COMPOSITION